A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer

Clinical trial NCT00055419 · COMPLETED

Trial details

NCT number: NCT00055419
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2003-02-01
Primary completion: 2004-07-01
Enrollment: 744

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.